Evidence map›Paper›PMID 24530608›Full record

ReviewTranslational research : the journal of laboratory and clinical medicine2014

Pericyte-endothelial crosstalk: implications and opportunities for advanced cellular therapies.

Anita Geevarghese, Ira M Herman

Abstract readReview
In one paragraph

Review in Translational research : the journal of laboratory and clinical medicine, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 146 papers.

0numbers the graph read from it
0cells of the map it votes in
146citing papers in PubMed
7.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

146 citing papers in PubMed, 232 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Mechanisms of Pericyte-Mediated Cancer Metastasis.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Review
  17. Review
  18. Review
  19. Article
  20. Article

86 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Anita GeevargheseProgram in Cellular and Molecular Physiology, Sackler School of Graduate Biomedical Sciences, Center for Innovations in Wound Healing Research, Tufts University School of Medicine, Boston, Mass.
Ira M HermanProgram in Cellular and Molecular Physiology, Sackler School of Graduate Biomedical Sciences, Center for Innovations in Wound Healing Research, Tufts University School of Medicine, Boston, Mass. Electronic address: iramherman@gmail.com.
Tufts University · US

Funding

Adipose Stem Cells for Diabetic RetinopathyR01EY022063 · NEI · UNIVERSITY OF VIRGINIA · PI HERMAN, IRA M, PEIRCE-COTTLER, SHAYN · 2012 to 2015
$2.0M
Regulating retinal microvascular morphogenesisR01EY015125 · NEI · TUFTS UNIVERSITY BOSTON · PI HERMAN, IRA M · 2004 to 2010
$1.7M
Pericytes, pathological angiogenesis and diabetic retinopathyR21EY019553 · NEI · TUFTS UNIVERSITY BOSTON · PI HERMAN, IRA M · 2009 to 2010
$452k
NEI NIH HHS EY 022063NEI NIH HHS EY 15125NEI NIH HHS R01 EY015125NEI NIH HHS R01 EY022063NEI NIH HHS R21 EY019553
6 · The paper itself

Abstract

Pericytes are mural cells of the microcirculation that have been shown to play key roles in regulating microvascular morphogenesis and stability throughout each tissue bed and organ system assessed. Of note, recent work has revealed that pericytes share several characteristics with mesenchymal- and adipose-derived stem cells, suggesting there may be lineage-related connections among bona fide pericytes and these vascular "progenitors," which can assume a perivascular position in association with endothelial cells. Hence, pericyte identity as a mediator of vascular remodeling may be confounded by its close relationships with its progenitors or pluripotent cell counterparts and yet demonstrates their potential utility as cell-based therapies for unmet clinical needs. Crucial to the development of such therapies is a comprehensive understanding of the origin and fate regulating these related cell types as well as the unveiling of the molecular mechanisms by which pericytes and endothelial cells communicate. Such mechanistic inputs, which disrupt normal cellular crosstalk during disease inception and progression, offer opportunities for intervention and are discussed in the context of the vasculopathies accompanying tumor growth, diabetes, and fibrosis.

Indexed as

AnimalsEndothelial CellsHumansPericytesRegenerative MedicineStem Cell Transplantation

Identifiers

PMID24530608
PMCPMC3976718
OpenAlexW2050497029

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.